Medprin Regenerative Medical Technologies Co. Ltd. (301033) - Total Liabilities

Latest as of June 2025: CN¥88.79 Million CNY ≈ $12.99 Million USD

Based on the latest financial reports, Medprin Regenerative Medical Technologies Co. Ltd. (301033) has total liabilities worth CN¥88.79 Million CNY (≈ $12.99 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 301033 cash flow conversion to assess how effectively this company generates cash.

Medprin Regenerative Medical Technologies Co. Ltd. - Total Liabilities Trend (2019–2024)

This chart illustrates how Medprin Regenerative Medical Technologies Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Medprin Regenerative Medical Technologie to evaluate the company's liquid asset resilience ratio.

Medprin Regenerative Medical Technologies Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Medprin Regenerative Medical Technologies Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Smartoptics Group AS OL:SMOP	Norway	Nkr23.55 Million
Suzhou Weizhixiang Food Co. Ltd. SHG:605089	China	CN¥74.73 Million
Memsensing Microsystems Suzhou China Co Ltd SHG:688286	China	CN¥137.97 Million
Shandong Donghong Pipe Ind Co SHG:603856	China	CN¥929.28 Million
Shanghai Titan Scientific Co. Ltd. A SHG:688133	China	CN¥2.00 Billion
Cooper Stnd NYSE:CPS	USA	$1.97 Billion
Bumble Inc NASDAQ:BMBL	USA	$743.97 Million

Liability Composition Analysis (2019–2024)

This chart breaks down Medprin Regenerative Medical Technologies Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 301033 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medprin Regenerative Medical Technologies Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)

The table below shows the annual total liabilities of Medprin Regenerative Medical Technologies Co. Ltd. from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥99.57 Million ≈ $14.57 Million	-34.11%
2023-12-31	CN¥151.11 Million ≈ $22.11 Million	+6.16%
2022-12-31	CN¥142.34 Million ≈ $20.83 Million	-16.72%
2021-12-31	CN¥170.92 Million ≈ $25.01 Million	+45.75%
2020-12-31	CN¥117.26 Million ≈ $17.16 Million	+214.62%
2019-12-31	CN¥37.27 Million ≈ $5.45 Million	--

About Medprin Regenerative Medical Technologies Co. Ltd.

SHE:301033 China Medical Devices

Market Cap

$540.22 Million

CN¥3.69 Billion CNY

Market Cap Rank

#12123 Global

#3735 in China

Share Price

CN¥55.06

Change (1 day)

-1.18%

52-Week Range

CN¥53.98 - CN¥88.80

All Time High

CN¥88.80